Recent trade makes Adma Biologics Inc (ADMA) Stock an appealing buy

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]

Are there any attempts to gain ground? Adma Biologics Inc (ADMA) Stock

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]

A Tale from the Dusty Corner: Adma Biologics Inc (ADMA) Stock

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]

Adma Biologics Inc (ADMA) Stock is Just Right Size-Neither Too Big Nor Too Small

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]

Adma Biologics Inc (ADMA) Stock: Thought Concerns

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]

It’s not the right time to quit: Adma Biologics Inc (ADMA) Stock

Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $5. The stock was initiated by […]